Learn More
BACKGROUND New drugs and regimens with the potential to transform tuberculosis treatment are presently in early stage clinical trials. OBJECTIVE The goal of the present study was to infer the required duration of these treatments. METHOD A meta-regression model was developed to predict relapse risk using treatment duration and month 2 sputum culture(More)
BACKGROUND Most psoriasis patients have mild to moderate disease, commonly treated topically. Current topical agents have limited efficacy and undesirable side effects associated with long-term use. Tofacitinib is a small molecule Janus kinase inhibitor investigated for the topical treatment of psoriasis. METHODS This was a 12-week, randomized,(More)
  • 1